Detailed Information

Cited 4 time in webofscience Cited 0 time in scopus
Metadata Downloads

Preliminary safety and efficacy of GX-17, a long-acting interleukin-7, in combination with pembrolizumab in patients with refractory or recurrent metastatic triple negative breast cancer (mTNBC): Dose escalation period of Phase Ib/II study (KEYNOTE-899).

Authors
Sohn, JoohyukPark, Kyong HwaAhn, Hee KyungLee, Keun SeokKim, Jee HyunKim, Sung-BaeLee, Kyoung EunKim, Jee HungYang, Se HwanLe, Ngocdiep T.Kim, JiwonHeo, MinKyuWoo, Jung-WonSung, Young ChulIm, Young Hyuck
Issue Date
May-2020
Publisher
AMER SOC CLINICAL ONCOLOGY
Citation
JOURNAL OF CLINICAL ONCOLOGY, v.38, no.15
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
Volume
38
Number
15
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/78431
ISSN
0732-183X
Files in This Item
There are no files associated with this item.
Appears in
Collections
의과대학 > 의학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ahn, Hee Kyung photo

Ahn, Hee Kyung
College of Medicine (Department of Medicine)
Read more

Altmetrics

Total Views & Downloads

BROWSE